CAM
MEDP icon

Cresset Asset Management’s Medpace MEDP Stock Holding History

Cresset Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-744
Closed -$227K – 1648
2025
Q1 		$227K Buy
+744
New +$250K ﹤0.01% 1463
2024
Q4 		– Sell
-2,348
Closed -$784K – 2022
2024
Q3 		$784K Sell
2,348
-19
-0.8% -$7.22K ﹤0.01% 1290
2024
Q2 		$975K Buy
2,367
+401
+20% +$159K ﹤0.01% 1082
2024
Q1 		$795K Buy
1,966
+681
+53% +$239K ﹤0.01% 1099
2023
Q4 		$394K Sell
1,285
-246
-16% -$66.4K ﹤0.01% 1350
2023
Q3 		$371K Buy
+1,531
New +$392K ﹤0.01% 1334

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Cresset Asset Management's MEDP Position: Q2 2025 in Review

Cresset Asset Management sold out of Medpace (MEDP) in Q2 2025, closing a stake of 744 shares — an estimated $227K sold.

Cresset Asset Management first reported a position in MEDP in Q3 2023 and held it in 6 quarters. The position peaked at $975K in Q2 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Cresset Asset Management reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Cresset Asset Management sold 744 Medpace shares in Q2 2025, an estimated $227K.
  • Cresset Asset Management first reported a position in Medpace in Q3 2023 and held it in 6 quarters.
  • Cresset Asset Management's Medpace position peaked at $975K in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.